If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad. In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development. Opportunities are listed according chronological order, the most recent first.

Model of Oral Gingival Tissue

Popular

Description

 Licensing opportunity

Demand:  In-vitro Models of Ginival  Tissue

The "TOP 10 Global Pharma Company" is seeking:

Novel in vitro models that mimic oral gingival tissue

They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading research-based pharmaceutical and healthcare company in the world, employing  100,000+  people in 100+  countries. 

Your product innovation combined with additional scientific expertise and world-class marketing can help them deliver innovative Consumer Healthcare brands around the world.  Seeker is committed to Open Innovation R&D  model.

Open Innovation is process for linking of external ideas or innovative technology with internal R&D and Commercial team responsible to grow new innovative and branded products. .

First you should  submit non-coofidential information about you innovative product or technology. Once submitted, your innovation idea is assigned to an Technology Transfer Manager at Farmavita.Net to guide the idea through early stage of assessment. After postive initial assessment of non-confidential information you will be asked to close the agency agreement with Farmavita.Net and to authorize us to manage you thorough the process of licensing negotiations. 

The ultimate goal of seeker is to in-license and commercializes innovative technologies, matching their strategic goals. Through appropriate legal agreements, seeker hope to link external innovative technology to their global brands – a process that can result in a win for product/technology seeker and a win for innovators.

Contact us for more details or to submit your non-confidential proposal!  

More details

Name Description
Pharma licensing In-licensing (demand)

Ad details

Ad ID : 308

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
406 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
342 Views
Profitable and Modern Russian CMO with long...
324 Views
Adalimumab API available: - from EU cGMP...
10027 Views
Infliximab API available: - from EU cGMP...
343 Views
Normal 0 false false false EN-US X-NONE HE /*...
334 Views
Start-up pharmaceutical company from South...
1679 Views